Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer
- 30 November 1997
- journal article
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 174 (5), 527-531
- https://doi.org/10.1016/s0002-9610(97)00151-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI Journal of the National Cancer Institute, 1996
- Another Look at Induction Chemotherapy for Organ Preservation in Patients With Head and Neck CancerJNCI Journal of the National Cancer Institute, 1996
- Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancerThe American Journal of Surgery, 1995
- Concurrent CIS-platinum and radiation with or without surgery for advanced head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerThe American Journal of Surgery, 1994
- Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II studyCancer, 1994
- Continuous Course Radiation Therapy and Concurrent Combination Chemotherapy for Squamous Cell Head and Neck CancerAmerican Journal of Clinical Oncology, 1994
- Double-blind randomized study of lonidamine and radiotherapy in head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer five-year results with impressive complete response rates and high survivalCancer, 1992
- Preoperative simultaneously administered cis‐platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neckHead & Neck Surgery, 1986